J-curve relation between daytime nap duration and type 2 diabetes or metabolic syndrome: A dose-response meta-analysis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yamada, Tomohide ^a   Shojima, Nobuhiro ^a   Yamauchi, Toshimasa ^a   Kadowaki, Takashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; HUMAN; META ANALYSIS; METABOLIC SYNDROME X; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ODDS RATIO; PHYSIOLOGY; RISK FACTOR; SLEEP;

AGED; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SLEEP;

EID: 85002731917     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38075     Document Type: Article

References (52)

1. Ohkuma, T. et al. Impact of sleep duration on obesity and the glycemic level in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Care. 36(3), 611-7 (2013).
2. Cappuccio, F. P., D'Elia, L., Strazzullo, P. & Miller, M. A. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-Analysis. Diabetes Care. 33, 414-420 (2010).
3. Cappuccio, F. P., Cooper, D., D'Elia, L., Strazzullo, P. & Miller, M. A. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-Analysis of prospective studies. Eur Heart J. 32(12), 1484-92 (2011).
4. Leng, Y. et al. Sleep duration and risk of fatal and nonfatal stroke: a prospective study and meta-Analysis. Neurology. 84(11), 1072-9 (2015).
5. Tamakoshi, A. & Ohno, Y. Self-reported sleep duration as a predictor of all-cause mortality: results from the JACC study, Japan. Sleep. 27, 51-54 (2004).
6. Shen, X., Wu, Y. & Zhang, D. Nighttime sleep duration, 24-hour sleep duration and risk of all-cause mortality among adults: a metaanalysis of prospective cohort studies. Sci Rep. 22, 21480 (2016).
7. Liu, Y., Wheaton, A. G., Chapman, D. P., Cunningham, T. J., Lu, H. & Croft, J. B. Prevalence of Healthy Sleep Duration among Adults-United States, 2014. Centers for Disease Control and Prevention: CDC. Available at: http://www.cdc.gov/mmwr/volumes/65/wr/mm6506a1.htm (accessed: 24th April 2016) (2014).
8. Guilleminault, C., Stoohs, R., Clerk, A., Cetel, M. & Maistros, P. A cause of excessive daytime sleepiness. The upper airway resistance syndrome. Chest. 104, 781-787 (1993).
9. Stang, A. et al. Heinz Nixdorf Recall Investigative Group. Midday naps and the risk of coronary artery disease: results of the Heinz Nixdorf Recall Study. Sleep. 35(12), 1705-12 (2012).
10. Jung, K. I., Song, C. H., Ancoli-Israel, S. & Barrett-Connor, E. Gender differences in nighttime sleep and daytime napping as predictors of mortality in older adults: the Rancho Bernardo study. Sleep Med. 14(1), 12-9 (2013).
11. Dhand, R. & Sohal. Good sleep, bad sleep! The role of daytime naps in healthy adults. Curr Opin Pulm Med. 12, 379-382 (2006).
12. Naska, A., Oikonomou, E., Trichopoulou, A., Psaltopoulou, T. & Trichopoulos, D. Siesta in healthy adults and coronary mortality in the general population. Arch Intern Med. 167, 296-301 (2007).
13. Asada, T., Motonaga, T., Yamagata, Z., Uno, M. & Takahashi, K. Associations between retrospectively recalled napping behavior and later development of Alzheimer's disease: association with APOE genotypes. Sleep. 23(5), 629-34 (2000).
14. Yamada, T., Hara, K., Shojima, N., Yamauchi, T. & Kadowaki, T. Daytime Napping and the Risk of Cardiovascular Disease and All-Cause Mortality: A Prospective Study and Dose-Response Meta-Analysis. Sleep. 38(12), 1945-53 (2015).
15. Stang, A. et al. Daily siesta, cardiovascular risk factors, and measures of subclinical atherosclerosis: results of the Heinz Nixdorf Recall Study. Sleep. 30(9), 1111-9 (2007).
16. Xu, Q. et al. Day napping and short night sleeping are associated with higher risk of diabetes in older adults. Diabetes Care. 33(1), 78-83 (2010).
17. Fang, W. et al. Longer habitual afternoon napping is associated with a higher risk for impaired fasting plasma glucose and diabetes mellitus in older adults: results from the Dongfeng-Tongji cohort of retired workers. Sleep Med. 14(10), 950-4 (2013).
18. Lam, K. B. et al. Napping is associated with increased risk of type 2 diabetes: the Guangzhou Biobank Cohort Study. Sleep. 33(3), 402-7 (2010).
19. Wu, J. et al. Daily sleep duration and risk of metabolic syndrome among middle-Aged and older Chinese adults: cross-sectional evidence from the Dongfeng-Tongji cohort study. BMC Public Health. 15, 178 (2015).
20. Lin, D. et al. Association between habitual daytime napping and metabolic syndrome: a population-based study. Metabolism. 63(12), 1520-7 (2014).
21. Lindberg, E., Berne, C., Franklin, K. A., Svensson, M. & Janson, C. Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women-A population-based study. Respir Med. 101(6), 1283-90 (2007).
22. Bixler, E. O. et al. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab. 90(8), 4510-5 (2005).
23. Renko, A. K., Hiltunen, L., Laakso, M., Rajala, U. & Keinänen-Kiukaanniemi, S. The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract. 67(1), 84-91 (2005).
24. Asplund, R. Daytime sleepiness and napping amongst the elderly in relation to somatic health and medical treatment. J Intern Med. 239(3), 261-7 (1996).
25. von Elm, E. et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 61(4), 344-9 (2008).
26. Wells, G. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses. Ottawa Hospital Research Institute. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp (Accessed 24th April 2016).
27. DerSimonian, R. & Laird, N. Meta-Analysis in clinical trials. Control Clin Trials. 7(3), 177-88 (1986).
28. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-Analysis. Stat Med. 21(11), 1539-58 (2002).
29. Altman, D. G. & Bland, J. M. Interaction revisited: the difference between two estimates. BMJ. 326, 219 (2003).
30. Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 50(4), 1088-101 (1994).
31. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-Analysis detected by a simple, graphical test. BMJ. 315, 629-34 (1997).
32. Orsini, N., Li, R., Wolk, A., Khudyakov, P. & Spiegelman, D. Meta-Analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 175(1), 66-73 (2012).
33. Harrell, F. E. Jr., Lee, K. L. & Pollock, B. G. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 80(15), 1198-202 (1988).
34. Orsini, N., Bellocco, R. & Greenland, S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 6(1), 40-57 (2006).
35. Shamseer, L. et al. PRISMA-P Group. Preferred reporting items for systematic review and meta-Analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 349, g7647 (2015).
36. Stroup, D. F. et al. Meta-Analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 283(15), 2008-12 (2000).
37. Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 151(4), W65-94 (2009).
38. Alberti, K. G., Zimmet, P. & Shaw, J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-A new worldwide definition. Lancet. 366(9491), 1059-62 (2005).
39. Zizi, F. et al. Sleep duration and the risk of diabetes mellitus: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep. 10(1), 43-7 (2010).
40. Spiegel, K., Knutson, K., Leproult, R., Tasali, E. & Van Cauter, E. Sleep loss: a novel risk factor for insulin resistance and type II diabetes. J Appl Physiol. 99, 2008-2019 (2005).
41. Gillberg, M., Kecklund, G., Axelsson, J. & Akerstedt, T. The effects of a short daytime nap after restricted night sleep. Sleep. 19(7), 570-5 (1996).
42. Hayashi, M., Ito, S. & Hori, T. The effects of a 20-min nap at noon on sleepiness, performance and EEG activity. Int J Psychophysiol. 32(2), 173-80 (1999).
43. Hayashi, M., Watanabe, M. & Hori, T. The effects of a 20 min nap in the mid-Afternoon on mood, performance and EEG activity. Clin Neurophysiol. 110(2), 272-9 (1999).
44. Takahashi, M. & Arito, H. Maintenance of alertness and performance by a brief nap after lunch under prior sleep deficit. Sleep. 23(6), 813-9 (2000).
45. Tietzel, A. J. & Lack, L. C. The short-term benefits of brief and long naps following nocturnal sleep restriction. Sleep. 24(3), 293-300 (2001).
46. Milner, C. E. & Cote, K. A. Benefits of napping in healthy adults: impact of nap length, time of day, age, and experience with napping. J Sleep Res. 18, 272-281 (2009).
47. Somers, V. K., Dyken, M. E., Clary, M. P. & Abboud, F. M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 96, 1897-1904 (1995).
48. Punjabi, N. M., Ahmed, M. M., Polotsky, V. Y., Beamer, B. A. & O'Donnell, C. P. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol. 136, 167-178 (2003).
49. Tasali, E., Mokhlesi, B. & Van Cauter, E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 133(2), 496-506 (2008).
50. Punjabi, N. M. & Polotsky, V. Y. Disorders of glucose metabolism in sleep apnea. Association of sleep time with diabetes mellitus and impaired glucose tolerance. J Appl Physiol. 99, 1998-2007 (2005).
51. Punjabi, N. M. et al.: Sleep-disordered breathing and insulin resistance in middle-Aged and overweight men. Am J Respir Crit Care Med. 165, 677-682 (2002).
52. Leng, Y. et al. Daytime napping, sleep duration and increased 8-year risk of type 2 diabetes in a British population. Nutr Metab Cardiovasc Dis. Jun 28. pii: S0939-4753(16)30086-2 (2016).